Dechra Pharmaceuticals, an England-based manufacturer of veterinary products, acquired Laboratorios Vencofarma do Brasil, a Brazilian company operating in the pharmaceutical sector for a total consideration of R$185m. Ian Page, Dechra's Chief Executive Officer commented, "We are delighted to acquire the Venco business, and to be able to establish a footprint in the rapidly expanding South American markets, with a broad portfolio of animal health products. Whilst the Venco business is performing and growing well, like the Brovel acquisition in 2016, we will invest to expand and further upgrade the business over the next 2 to 3 years to create increased value to Dechra and its stakeholders."